In March 2023, the U.S. Food and Drug Administration (FDA) issued voluntary recalls for two more eye drop brands, Apotex: Brimonidine Tartrate Ophthalmic Solution, 0.15%, and Purely Soothing: 15% MSM Drops, due to sterility concerns. This followed the February 2023 recall of EzriCare & Delsma Pharma’s Artificial Tears Lubricant Eye Drops and Artificial Eye Ointment, which were linked to an outbreak of drug-resistant Pseudomonas aeruginosa infections, causing severe eye inflammation, vision loss, and death.
Bacterial contamination of eye drops can have serious consequences, with possible complications ranging from severe infections to blindness. Manufacturers are becoming increasingly vigilant about the sterility of their products, and customers are advised to discontinue use of recalled products immediately and seek medical treatment if they have experienced any problems.
If you have used a recalled product and experienced adverse reactions, you should consider consulting with a lawyer to explore your legal options. Injuries caused by contaminated eye drops can result in significant financial and emotional damages to affected individuals and their families, including medical expenses, lost wages, pain and suffering, and loss of quality of life. Reporting adverse reactions to the FDA’s MedWatch Adverse Event Reporting program can also help prevent future injuries and illnesses.
Share this: